Allergan (NYSE:AGN) to Release Q2 2008 Earnings July 30

Allergan (NYSE:AGN) will release the second quarter earnings for 2008 on Wednesday, July 30.  The financial results will be posted on the company’s website at agn360.client.shareholder.com/earnings.cfm.

Allergan, Inc. is a multi-specialty healthcare company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company discovers, develops and commercializes specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets in more than 100 countries around the world.

In January 2007, Allergan, Inc. acquired all of the outstanding capital stock of Groupe Corneal Laboratoires (Corneal), a healthcare company that develops, manufactures and markets dermal fillers, viscoelastics, and a range of ophthalmic surgical device products.

In October 2007, the Company acquired all of the outstanding capital stock of Esprit Pharma Holding Company, Inc. (Esprit). Allergan, Inc. operates in two business segments: specialty pharmaceuticals and medical devices.

Read more Business News on The Global Market Directory at:

http://thegmd.finditt.com/News.aspx

By creating a business networking profile on YourFindit visitors to your profile can view a company “About Us,” uploaded videos, posted pictures and blogs and distributed press releases. A company can also create its unique YourFindit URL and screen name that serve to increase their presence on search engines as well as post a direct link to their company Web site and network with other companies and individuals.

Join the business networking community, YourFindit and create a profile.